These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 72935)

  • 1. "Off period" dystonia and "on period" choreoathetosis in levodopa-treated patients with Parkinson's disease.
    Lees AJ; Shaw KM; Stern GM
    Lancet; 1977 Nov; 2(8046):1034. PubMed ID: 72935
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease and levodopa. A five-year follow-up and review.
    Markham CH; Treciokas LJ; Diamond SG
    West J Med; 1974 Sep; 121(3):188-206. PubMed ID: 4606887
    [No Abstract]   [Full Text] [Related]  

  • 3. The "on-off" side effect of L-DOPA.
    Markham CH
    Adv Neurol; 1974; 5():387-96. PubMed ID: 4440586
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of manganese in dystonia.
    Barbeau A; Inoué N; Cloutier T
    Adv Neurol; 1976; 14():339-52. PubMed ID: 821321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity.
    Krack P; Pollak P; Limousin P; Benazzouz A; Deuschl G; Benabid AL
    Brain; 1999 Jun; 122 ( Pt 6)():1133-46. PubMed ID: 10356065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced movement disorders.
    North RR
    Postgrad Med; 1971 Sep; 50(3):180-5. PubMed ID: 5092993
    [No Abstract]   [Full Text] [Related]  

  • 7. Involuntary movement disorders.
    Still CN
    Neurol Clin; 1984 Feb; 2(1):71-89. PubMed ID: 6239089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma dopa concentrations and the "on-off" effect after chronic treatment of Parkinson's disease.
    Sweet RD; McDowell FH
    Neurology; 1974 Oct; 24(10):953-6. PubMed ID: 4472237
    [No Abstract]   [Full Text] [Related]  

  • 9. "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy.
    Marsden CD; Parkes JD
    Lancet; 1976 Feb; 1(7954):292-6. PubMed ID: 55599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson's disease.
    Pourcher E; Bonnet AM; Kefalos J; Dubois B; Agid Y
    Mov Disord; 1989; 4(3):195-201. PubMed ID: 2779590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
    Marsden CD
    Mod Trends Neurol; 1975; 6():141-66. PubMed ID: 127927
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutics of disordered movement.
    Sears ES
    Am Fam Physician; 1977 Sep; 16(3):145-54. PubMed ID: 143204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antagonism and competition between Parkinson's syndrome and the chorea and athetosis syndrome. Clinical cases of the association (including an anatomoclinical case). The abnormal movements provoked by levodopa in Parkinsonian patients].
    Sigwald J; Chomette G; Raymondeaud C
    Sem Hop; 1972 Feb; 48(9):609-24. PubMed ID: 4339429
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous dopaminergic stimulation for Parkinson's disease: facts and fancy.
    Obeso JA; Grandas F; Vaamonde J; Luquin MR; Martinez-Lage JM
    Funct Neurol; 1988; 3(4):413-27. PubMed ID: 3072277
    [No Abstract]   [Full Text] [Related]  

  • 15. Forms of dystonia in patients with Parkinson's disease.
    Kidron D; Melamed E
    Neurology; 1987 Jun; 37(6):1009-11. PubMed ID: 3587617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "On-off" syndrome treated with lithium carbonate: a case report.
    Ross DR; Coffey CE; Ferren EL; Walker JI; Olanow CW
    Am J Psychiatry; 1981 Dec; 138(12):1626-7. PubMed ID: 6795945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil induced choreoathetosis in men with Parkinson's disease.
    Perkovic O; Vitezic D; Rudez J; Vitezic M; Kovacevic M; Mrsic-Pelcic J; Ljubicic D; Jurjevic A
    Int J Clin Pharmacol Ther; 2010 Jan; 48(1):76-8. PubMed ID: 20040342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches to the study of cerebral dopamine metabolism in certain extrapyramidal diseases.
    Barkhatova VP; Kandel' EI; Demina EG
    Neurosci Behav Physiol; 1985; 15(2):132-9. PubMed ID: 3160969
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of age at onset on progression and mortality in Parkinson's disease.
    Diamond SG; Markham CH; Hoehn MM; McDowell FH; Muenter MD
    Neurology; 1989 Sep; 39(9):1187-90. PubMed ID: 2771070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.
    Tarsy D; Parkes JD; Marsden CD
    J Neurol Neurosurg Psychiatry; 1975 Apr; 38(4):331-5. PubMed ID: 1095689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.